Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
about
Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivityTheZisomer of 2,4-diaminofuro[2,3-d]pyrimidine antifolate promotes unusual crystal packing in a human dihydrofolate reductase ternary complexPreclinical Evaluation of the Antifolate QN254, 5-Chloro- N'6'-(2,5-Dimethoxy-Benzyl)-Quinazoline-2,4,6-Triamine, as an Antimalarial Drug CandidateDiscovery of Potent and Selective Inhibitors of Toxoplasma gondii Thymidylate Synthase for Opportunistic InfectionsAntimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductaseIsolation of rat dihydrofolate reductase gene and characterization of recombinant enzymeDicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlationsIn vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex.CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agentsReview of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.Identification of Structurally Diverse Antimicrobials Through Sequential Application of Pharmacophore Modeling, Virtual Screening, Molecular Docking and In Vitro Microbiological Assay.Protein unfolding is not a prerequisite for endoplasmic reticulum-to-cytosol dislocation.
P2860
Q26782581-CA2C20FA-71D6-482F-8A69-EEB927D164D3Q27656874-32B72304-0A7E-433F-8913-ECAE338BB179Q27660357-B8D82EB3-9A30-4273-8A40-B8138F0BE2ACQ27681485-FB9C9ABA-765A-4706-858A-9FC2D10D35CBQ28344754-1F3D0CAB-AD3A-45DC-8C41-672C034EDA27Q28345962-26C04C09-B723-46D0-AB6A-BABE085676FFQ28364098-DCB25029-E69A-4741-AE77-180FE2A98109Q28369332-7A7882C2-98A8-438D-884A-3F1C69266CE5Q30483442-6826B7BA-A1D9-41AA-9E67-0B01BEBF6273Q37428599-6E3722C7-2C5B-48BC-8E25-39C899F891FBQ39944839-575D8D70-D9E3-4859-9BC0-5A65ABDF1519Q44249690-3CF0103E-AFEB-4B0C-BE95-10FB0B1E36B0
P2860
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Lipophilic antifolates as agen ...... rinii in in vitro evaluations.
@en
Lipophilic antifolates as agen ...... rinii in in vitro evaluations.
@nl
type
label
Lipophilic antifolates as agen ...... rinii in in vitro evaluations.
@en
Lipophilic antifolates as agen ...... rinii in in vitro evaluations.
@nl
prefLabel
Lipophilic antifolates as agen ...... rinii in in vitro evaluations.
@en
Lipophilic antifolates as agen ...... rinii in in vitro evaluations.
@nl
P2093
P356
P1476
Lipophilic antifolates as agen ...... rinii in in vitro evaluations.
@en
P2093
Johnson CA
Pfefferkorn ER
Queener SF
P304
P356
10.1021/JM950760Y
P407
P577
1996-03-01T00:00:00Z